Cargando…
Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
Bluetongue virus (BTV) is an emerging transboundary disease in Europe, which can cause significant production losses among ruminants. The analysis presented here assessed the costs of BTV surveillance and vaccination programmes in Austria and Switzerland between 2007 and 2016. Costs were compared wi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870441/ https://www.ncbi.nlm.nih.gov/pubmed/29363572 http://dx.doi.org/10.1136/vr.104448 |
_version_ | 1783309482402512896 |
---|---|
author | Pinior, Beate Firth, Clair L Loitsch, Angelika Stockreiter, Simon Hutter, Sabine Richter, Veronika Lebl, Karin Schwermer, Heinzpeter Käsbohrer, Annemarie |
author_facet | Pinior, Beate Firth, Clair L Loitsch, Angelika Stockreiter, Simon Hutter, Sabine Richter, Veronika Lebl, Karin Schwermer, Heinzpeter Käsbohrer, Annemarie |
author_sort | Pinior, Beate |
collection | PubMed |
description | Bluetongue virus (BTV) is an emerging transboundary disease in Europe, which can cause significant production losses among ruminants. The analysis presented here assessed the costs of BTV surveillance and vaccination programmes in Austria and Switzerland between 2007 and 2016. Costs were compared with respect to time, type of programme, geographical area and who was responsible for payment. The total costs of the BTV vaccination and surveillance programmes in Austria amounted to €23.6 million, whereas total costs in Switzerland were €18.3 million. Our analysis demonstrates that the costs differed between years and geographical areas, both within and between the two countries. Average surveillance costs per animal amounted to approximately €3.20 in Austria compared with €1.30 in Switzerland, whereas the average vaccination costs per animal were €6.20 in Austria and €7.40 in Switzerland. The comparability of the surveillance costs is somewhat limited, however, due to differences in each nation’s surveillance (and sampling) strategy. Given the importance of the export market for cattle production, investments in such programmes are more justified for Austria than for Switzerland. The aim of the retrospective assessment presented here is to assist veterinary authorities in planning and implementing cost-effective and efficient control strategies for emerging livestock diseases. |
format | Online Article Text |
id | pubmed-5870441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58704412018-03-28 Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) Pinior, Beate Firth, Clair L Loitsch, Angelika Stockreiter, Simon Hutter, Sabine Richter, Veronika Lebl, Karin Schwermer, Heinzpeter Käsbohrer, Annemarie Vet Rec Paper Bluetongue virus (BTV) is an emerging transboundary disease in Europe, which can cause significant production losses among ruminants. The analysis presented here assessed the costs of BTV surveillance and vaccination programmes in Austria and Switzerland between 2007 and 2016. Costs were compared with respect to time, type of programme, geographical area and who was responsible for payment. The total costs of the BTV vaccination and surveillance programmes in Austria amounted to €23.6 million, whereas total costs in Switzerland were €18.3 million. Our analysis demonstrates that the costs differed between years and geographical areas, both within and between the two countries. Average surveillance costs per animal amounted to approximately €3.20 in Austria compared with €1.30 in Switzerland, whereas the average vaccination costs per animal were €6.20 in Austria and €7.40 in Switzerland. The comparability of the surveillance costs is somewhat limited, however, due to differences in each nation’s surveillance (and sampling) strategy. Given the importance of the export market for cattle production, investments in such programmes are more justified for Austria than for Switzerland. The aim of the retrospective assessment presented here is to assist veterinary authorities in planning and implementing cost-effective and efficient control strategies for emerging livestock diseases. BMJ Publishing Group 2018-03-03 2018-01-23 /pmc/articles/PMC5870441/ /pubmed/29363572 http://dx.doi.org/10.1136/vr.104448 Text en © British Veterinary Association (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Paper Pinior, Beate Firth, Clair L Loitsch, Angelika Stockreiter, Simon Hutter, Sabine Richter, Veronika Lebl, Karin Schwermer, Heinzpeter Käsbohrer, Annemarie Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) |
title | Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) |
title_full | Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) |
title_fullStr | Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) |
title_full_unstemmed | Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) |
title_short | Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) |
title_sort | cost distribution of bluetongue surveillance and vaccination programmes in austria and switzerland (2007–2016) |
topic | Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870441/ https://www.ncbi.nlm.nih.gov/pubmed/29363572 http://dx.doi.org/10.1136/vr.104448 |
work_keys_str_mv | AT piniorbeate costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT firthclairl costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT loitschangelika costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT stockreitersimon costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT huttersabine costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT richterveronika costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT leblkarin costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT schwermerheinzpeter costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 AT kasbohrerannemarie costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016 |